Annual accounts receivable:
$228.54M+$49.02M(+27.30%)Summary
- As of today (August 16, 2025), COLL annual accounts receivable is $228.54 million, with the most recent change of +$49.02 million (+27.30%) on December 31, 2024.
- During the last 3 years, COLL annual accounts receivable has risen by +$122.70 million (+115.92%).
- COLL annual accounts receivable is now at all-time high.
Performance
COLL Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$213.02M-$15.69M(-6.86%)Summary
- As of today (August 16, 2025), COLL quarterly accounts receivable is $213.02 million, with the most recent change of -$15.69 million (-6.86%) on June 1, 2025.
- Over the past year, COLL quarterly accounts receivable has increased by +$29.17 million (+15.86%).
- COLL quarterly accounts receivable is now -6.86% below its all-time high of $228.71 million, reached on March 31, 2025.
Performance
COLL Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
COLL Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.3% | +15.9% |
| 3 y3 years | +115.9% | +7.9% |
| 5 y5 years | +213.3% | +162.4% |
COLL Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +115.9% | -6.9% | +27.2% |
| 5 y | 5-year | at high | +213.3% | -6.9% | +178.6% |
| alltime | all time | at high | >+9999.0% | -6.9% | >+9999.0% |
COLL Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $213.02M(-6.9%) |
| Mar 2025 | - | $228.71M(+0.1%) |
| Dec 2024 | $228.54M(+27.3%) | $228.54M(+0.0%) |
| Sep 2024 | - | $228.46M(+24.3%) |
| Jun 2024 | - | $183.85M(+5.2%) |
| Mar 2024 | - | $174.69M(-2.7%) |
| Dec 2023 | $179.53M(-2.0%) | $179.53M(-1.3%) |
| Sep 2023 | - | $181.85M(+8.6%) |
| Jun 2023 | - | $167.48M(-6.5%) |
| Mar 2023 | - | $179.13M(-2.2%) |
| Dec 2022 | $183.12M(+73.0%) | $183.12M(-6.3%) |
| Sep 2022 | - | $195.40M(-1.1%) |
| Jun 2022 | - | $197.50M(+18.7%) |
| Mar 2022 | - | $166.34M(+57.2%) |
| Dec 2021 | $105.84M(+27.0%) | $105.84M(-29.0%) |
| Sep 2021 | - | $149.00M(+65.4%) |
| Jun 2021 | - | $90.10M(-3.3%) |
| Mar 2021 | - | $93.16M(+11.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $83.32M(+14.2%) | $83.32M(+9.0%) |
| Sep 2020 | - | $76.47M(-5.8%) |
| Jun 2020 | - | $81.19M(-5.0%) |
| Mar 2020 | - | $85.43M(+17.1%) |
| Dec 2019 | $72.95M(-6.4%) | $72.95M(-13.5%) |
| Sep 2019 | - | $84.38M(+3.8%) |
| Jun 2019 | - | $81.28M(-4.5%) |
| Mar 2019 | - | $85.14M(+9.2%) |
| Dec 2018 | $77.95M(+681.9%) | $77.95M(+17.2%) |
| Sep 2018 | - | $66.53M(-2.7%) |
| Jun 2018 | - | $68.38M(+3.5%) |
| Mar 2018 | - | $66.04M(+562.4%) |
| Dec 2017 | $9.97M(+368.2%) | $9.97M(+71.2%) |
| Sep 2017 | - | $5.82M(+19.4%) |
| Jun 2017 | - | $4.88M(+45.6%) |
| Mar 2017 | - | $3.35M(+57.3%) |
| Dec 2016 | $2.13M | $2.13M(+26.8%) |
| Sep 2016 | - | $1.68M(-43.1%) |
| Jun 2016 | - | $2.95M |
FAQ
- What is Collegium Pharmaceutical, Inc. annual accounts receivable?
- What is the all time high annual accounts receivable for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. annual accounts receivable year-on-year change?
- What is Collegium Pharmaceutical, Inc. quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. quarterly accounts receivable year-on-year change?
What is Collegium Pharmaceutical, Inc. annual accounts receivable?
The current annual accounts receivable of COLL is $228.54M
What is the all time high annual accounts receivable for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high annual accounts receivable is $228.54M
What is Collegium Pharmaceutical, Inc. annual accounts receivable year-on-year change?
Over the past year, COLL annual accounts receivable has changed by +$49.02M (+27.30%)
What is Collegium Pharmaceutical, Inc. quarterly accounts receivable?
The current quarterly accounts receivable of COLL is $213.02M
What is the all time high quarterly accounts receivable for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high quarterly accounts receivable is $228.71M
What is Collegium Pharmaceutical, Inc. quarterly accounts receivable year-on-year change?
Over the past year, COLL quarterly accounts receivable has changed by +$29.17M (+15.86%)